小分子和化合物库
            选项
        
        
    - 
                        Avelumab (anti-PD-L1)关联靶标: CD274- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse), 狗(Dog), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1537032-82-8 Compound CID : 168266339IUPAC Name: See moreSMILES: See moreInChIKey: YRKYEQYAGDIKGE-UHFFFAOYSA-NInChI: See more
- 
                        Pamrevlumab (anti-CTGF)关联靶标: CTGF- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 946415-13-0
- 
                        Tiragolumab (anti-TIGIT)关联靶标: TIGIT- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1918185-84-8
- 
                        Lampalizumab (anti-Complement Factor D)关联靶标: CFD- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1278466-20-8
- 
                        Osocimab (anti-Factor XI)关联靶标: F11- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 2056878-75-0
- 
                        Zansecimab (anti-ANGPT2)关联靶标: ANGPT2- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse), 狗(Dog), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 2415205-37-5
- 
                        Benralizumab (anti-IL-5Ra)关联靶标: IL5RA- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1044511-01-4
- 
                        Mirikizumab (anti-IL-23)关联靶标: IL23A- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1884201-71-1
- 
                        Timolumab (anti-AOC3)关联靶标: AOC3- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1073538-99-4
- 
                        Ranibizumab (anti-VEGFA)关联靶标: VEGFA- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1-CH1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit)
- 亚型: Human IgG1-CH1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 347396-82-1
- 
                        Concizumab (anti-TFPI)关联靶标: TFPI- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 恒河猴(Rhesus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号: 1312299-39-0
- 
                        RG7992 (anti-Klotho Beta)关联靶标: KLB- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 兔(Rabbit), 大鼠(Rat), 小鼠(Mouse), 恒河猴(Rhesus monkey), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 
 首页
首页 400-620-6333
400-620-6333











